118 related articles for article (PubMed ID: 1933335)
1. Protection and potentiation of MPTP-induced toxicity by cytochrome P-450 inhibitors and inducer: in vitro studies with brain slices.
Pai KS; Ravindranath V
Brain Res; 1991 Aug; 555(2):239-44. PubMed ID: 1933335
[TBL] [Abstract][Full Text] [Related]
2. Protection and potentiation of 1-methyl-4-phenylpyridinium-induced toxicity by cytochrome P450 inhibitors and inducer may be due to the altered uptake of the toxin.
Sriram K; Pai KS; Ravindranath V
J Neurochem; 1995 Mar; 64(3):1203-8. PubMed ID: 7861152
[TBL] [Abstract][Full Text] [Related]
3. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
4. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
[TBL] [Abstract][Full Text] [Related]
5. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
Heikkila RE; Duvoisin RC; Finberg JP; Youdim MB
Eur J Pharmacol; 1985 Oct; 116(3):313-7. PubMed ID: 3935467
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Gaál J; Solti M; Kollár E; Singer J
J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
[TBL] [Abstract][Full Text] [Related]
9. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl.
Valoti M; Fusi F; Frosini M; Pessina F; Tipton KF; Sgaragli GP
Eur J Pharmacol; 2000 Mar; 391(3):199-206. PubMed ID: 10729359
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors.
Wu RF; Ichikawa Y
FEBS Lett; 1995 Jan; 358(2):145-8. PubMed ID: 7828725
[TBL] [Abstract][Full Text] [Related]
12. MPTP neurotoxicity to cerebellar Purkinje cells in mice.
Takada M; Sugimoto T; Hattori T
Neurosci Lett; 1993 Feb; 150(1):49-52. PubMed ID: 8469402
[TBL] [Abstract][Full Text] [Related]
13. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
Lydén-Sokolowski A; Larsson BS; Lindquist NG
Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
[TBL] [Abstract][Full Text] [Related]
14. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice.
Sriram K; Pai KS; Boyd MR; Ravindranath V
Brain Res; 1997 Feb; 749(1):44-52. PubMed ID: 9070626
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Cohen G; Mytilineou C
Life Sci; 1985 Jan; 36(3):237-42. PubMed ID: 3917526
[TBL] [Abstract][Full Text] [Related]
18. Effects of inducers and inhibitors of cytochrome P-450-linked monooxygenases on the toxicity, in vitro metabolism and in vivo irreversible binding of 2-methylnaphthalene in mice.
Griffin KA; Johnson CB; Breger RK; Franklin RB
J Pharmacol Exp Ther; 1982 Jun; 221(3):517-24. PubMed ID: 7086669
[No Abstract] [Full Text] [Related]
19. The influence of metabolism on the MAO-B inhibitory potency of selegiline.
Haberle D; Szökõ E; Magyar K
Curr Med Chem; 2002 Jan; 9(1):47-51. PubMed ID: 11860347
[TBL] [Abstract][Full Text] [Related]
20. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
Ofori S; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):258-66. PubMed ID: 2571719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
